-
Je něco špatně v tomto záznamu ?
Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets
K. Dvorácková, M. Rabisková, R. Masteiková, J. Muselík, K. Krejcová,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antiflogistika nesteroidní aplikace a dávkování chemie MeSH
- časové faktory MeSH
- diklofenak aplikace a dávkování chemie MeSH
- laktosa chemie MeSH
- léky s prodlouženým účinkem MeSH
- mastné alkoholy chemie MeSH
- nosiče léků chemie MeSH
- pomocné látky chemie MeSH
- povidon chemie MeSH
- rozpustnost MeSH
- sacharosa chemie MeSH
- tablety MeSH
- velikost částic MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The purpose of this experimental work was the development of hydrophilic-lipophilic matrix tablets for controlled release of slightly soluble drug represented here by diclofenac sodium (DS). Drug dissolution profile optimization provided by soluble filler was studied. Matrix tablets were based on cetyl alcohol as the lipophilic carrier, povidone as the gel-forming agent, and common soluble filler, that is lactose or sucrose of different particle size. Physical properties of tablets prepared by melt granulation and drug release in a phosphate buffer of pH 6.8 were evaluated. In vitro studies showed that used filler type, filler to povidone ratio and sucrose particle size influenced the drug release rate. DS dissolution profile could be changed within a wide range from about 50% per 24 hours to almost 100% in 10 hours. The release constant values confirmed that DS was released from matrices by the diffusion and anomalous transport. The influence of sucrose particle size on the drug release rate was observed. As the particle size decreased, the drug release increased significantly and its dissolution profile became more uniform. Soluble fillers participated in the pore-forming process according to their solubility and particle size. Formulations containing 100 mg of the drug, 80 mg of cetyl alcohol, 40 mg of povidone, and 80 mg of either lactose or sucrose (particle size 250-125 microm) were considered optimal for 24-hour lasting dissolution of DS.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026050
- 003
- CZ-PrNML
- 005
- 20121207095005.0
- 007
- ta
- 008
- 120817s2009 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1080/03639040802710243 $2 doi
- 035 __
- $a (PubMed)19274510
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Dvorácková, Katerina $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 245 10
- $a Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets / $c K. Dvorácková, M. Rabisková, R. Masteiková, J. Muselík, K. Krejcová,
- 520 9_
- $a The purpose of this experimental work was the development of hydrophilic-lipophilic matrix tablets for controlled release of slightly soluble drug represented here by diclofenac sodium (DS). Drug dissolution profile optimization provided by soluble filler was studied. Matrix tablets were based on cetyl alcohol as the lipophilic carrier, povidone as the gel-forming agent, and common soluble filler, that is lactose or sucrose of different particle size. Physical properties of tablets prepared by melt granulation and drug release in a phosphate buffer of pH 6.8 were evaluated. In vitro studies showed that used filler type, filler to povidone ratio and sucrose particle size influenced the drug release rate. DS dissolution profile could be changed within a wide range from about 50% per 24 hours to almost 100% in 10 hours. The release constant values confirmed that DS was released from matrices by the diffusion and anomalous transport. The influence of sucrose particle size on the drug release rate was observed. As the particle size decreased, the drug release increased significantly and its dissolution profile became more uniform. Soluble fillers participated in the pore-forming process according to their solubility and particle size. Formulations containing 100 mg of the drug, 80 mg of cetyl alcohol, 40 mg of povidone, and 80 mg of either lactose or sucrose (particle size 250-125 microm) were considered optimal for 24-hour lasting dissolution of DS.
- 650 _2
- $a antiflogistika nesteroidní $x aplikace a dávkování $x chemie $7 D000894
- 650 _2
- $a léky s prodlouženým účinkem $7 D003692
- 650 _2
- $a diklofenak $x aplikace a dávkování $x chemie $7 D004008
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a mastné alkoholy $x chemie $7 D005233
- 650 _2
- $a laktosa $x chemie $7 D007785
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a povidon $x chemie $7 D011205
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a sacharosa $x chemie $7 D013395
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rabisková, Miloslava
- 700 1_
- $a Masteiková, Ruta
- 700 1_
- $a Muselík, Jan
- 700 1_
- $a Krejcová, Katerina
- 773 0_
- $w MED00001439 $t Drug development and industrial pharmacy $x 1520-5762 $g Roč. 35, č. 8 (2009), s. 930-40
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/19274510 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207095039 $b ABA008
- 999 __
- $a ok $b bmc $g 948092 $s 783396
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2009 $b 35 $c 8 $d 930-40 $i 1520-5762 $m Drug development and industrial pharmacy $n Drug Dev Ind Pharm $x MED00001439
- LZP __
- $a Pubmed-20120817/10/03